TNF and Hypoglycemia: Furthermore, when we increased the dose of anti-TNF-α to 500 μg/mouse to treat anti-CD3-injected mice, no reversal of hypoglycemia was observed (see supplemental Figure 1 in Supplementery Material available online at http://dx.doi.org/10.1155/2014/326708).